Your browser doesn't support javascript.
loading
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes.
Esagian, Stepan M; Khaki, Ali Raza; Diamantopoulos, Leonidas N; Carril-Ajuria, Lucia; Castellano, Daniel; De Kouchkovsky, Ivan; Park, Joseph J; Alva, Ajjai; Bilen, Mehmet A; Stewart, Tyler F; McKay, Rana R; Santos, Victor S; Agarwal, Neeraj; Jain, Jayanshu; Zakharia, Yousef; Morales-Barrera, Rafael; Devitt, Michael E; Nelson, Ariel; Hoimes, Christopher J; Shreck, Evan; Gartrell, Benjamin A; Sankin, Alex; Tripathi, Abhishek; Zakopoulou, Roubini; Bamias, Aristotelis; Rodriguez-Vida, Alejo; Drakaki, Alexandra; Liu, Sandy; Kumar, Vivek; Lythgoe, Mark P; Pinato, David J; Murgic, Jure; Fröbe, Ana; Joshi, Monika; Isaacsson Velho, Pedro; Hahn, Noah; Alonso Buznego, Lucia; Duran, Ignacio; Moses, Marcus; Barata, Pedro; Galsky, Matthew D; Sonpavde, Guru; Yu, Evan Y; Msaouel, Pavlos; Koshkin, Vadim S; Grivas, Petros.
Affiliation
  • Esagian SM; Faculty of Medicine, School of Health Sciences, Democritus University of Thrace, Alexandroupolis, Greece.
  • Khaki AR; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Diamantopoulos LN; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Carril-Ajuria L; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Castellano D; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • De Kouchkovsky I; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Park JJ; Division of Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Alva A; Division of Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Bilen MA; Division of Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Stewart TF; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • McKay RR; Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
  • Santos VS; Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
  • Agarwal N; Division of Oncology, Department of Medicine, University of Utah, Salt Lake City, UT, USA.
  • Jain J; Division of Oncology, Department of Medicine, University of Utah, Salt Lake City, UT, USA.
  • Zakharia Y; Department of Medicine, University of Iowa, Iowa City, IA, USA.
  • Morales-Barrera R; Division of Oncology, Department of Medicine, University of Iowa, Iowa City, IA, USA.
  • Devitt ME; Vall d'Hebron Institute of Oncology, Vall d' Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Nelson A; Division of Hematology/Oncology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA, USA.
  • Hoimes CJ; Division of Medical Oncology, Seidman Cancer Center at Case Comprehensive Cancer Center, Cleveland, OH, USA.
  • Shreck E; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Gartrell BA; Division of Medical Oncology, Seidman Cancer Center at Case Comprehensive Cancer Center, Cleveland, OH, USA.
  • Sankin A; Division of Medical Oncology, Duke University, Durham, NC, USA.
  • Tripathi A; Department of Medical Oncology and Urology, Montefiore Medical Center, Bronx, NY, USA.
  • Zakopoulou R; Department of Medical Oncology and Urology, Montefiore Medical Center, Bronx, NY, USA.
  • Bamias A; Department of Medical Oncology and Urology, Montefiore Medical Center, Bronx, NY, USA.
  • Rodriguez-Vida A; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Drakaki A; Department of Clinical Therapeutics, School of Medicine, Alexandra General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Liu S; 2nd Propaedeutic Dept of Internal Medicine, School of Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Kumar V; Medical Oncology Department, Hospital del Mar Research Institute, Barcelona, Spain.
  • Lythgoe MP; Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Pinato DJ; Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Murgic J; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Fröbe A; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Joshi M; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Isaacsson Velho P; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia.
  • Hahn N; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia.
  • Alonso Buznego L; School of Dental Medicine, Zagreb, Croatia.
  • Duran I; Division of Hematology/Oncology, Department of Medicine, Penn State Cancer Institute, Hershey, PA, USA.
  • Moses M; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
  • Barata P; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
  • Galsky MD; Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.
  • Sonpavde G; Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.
  • Yu EY; Deming Department of Medicine, Section of Hematology/Oncology, Tulane University, New Orleans, LA, USA.
  • Msaouel P; Deming Department of Medicine, Section of Hematology/Oncology, Tulane University, New Orleans, LA, USA.
  • Koshkin VS; Division of Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Grivas P; Genitourinary Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
BJU Int ; 128(2): 196-205, 2021 08.
Article in En | MEDLINE | ID: mdl-33556233
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Transitional Cell / Urologic Neoplasms / Immune Checkpoint Inhibitors Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2021 Type: Article Affiliation country: Greece
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Transitional Cell / Urologic Neoplasms / Immune Checkpoint Inhibitors Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2021 Type: Article Affiliation country: Greece